Copyright
©The Author(s) 2020.
World J Clin Cases. Dec 6, 2020; 8(23): 6071-6079
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.6071
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.6071
Figure 1 Fundus photographs revealing venous dilation, tortuosity, and macular edema in the right eye and macular edema, extensive hemorrhages, and cotton wool spots in the left eye.
A: The right eye; B: The left eye.
Figure 2 Bone marrow examination results.
A: Bone marrow aspiration smears. Plasmacytoid cells are labelled with arrows; B: Bone marrow biopsy showed diffused infiltration by small lymphoid and plasmacytoid cells by hematoxylin and eosin staining; C: Flow cytometry assay showed that the populations in P3 group (8.3%) were mature clonal B cells, mainly expressing CD19, CD20, CD22, CXCR4, and HLA-DR and partially expressing cKappa.
Figure 3 Spectral domain optical coherence tomography images.
A: Serous macular detachment with intraretinal edema in the outer plexiform layer (OPL). Central retinal thickness (CRT) = 607 µm, and central choroidal thickness (CCT) = 148 µm (right eye); B: Intraretinal edema in the OPL. CRT = 1101 µm, and CCT = 123 µm (left eye); C: 1 mo after intravitreal ranibizumab (IVR). CRT = 530 µm, and CCT = 155 µm (right eye); D: 1 mo after IVR. CRT = 976 µm, and CCT = 113 µm (left eye); E: 6 mo after IVR. Complete resolution of intraretinal edema was achieved. CRT = 500 µm, and CCT = 131 µm (right eye); F: 6 mo after IVR. Nearly complete resolution of intraretinal edema was achieved. CRT = 559 µm, and CCT = 90 µm (left eye).
Figure 4 Transverse optical coherence tomography angiograms showing the disrupted retinal vasculature and intraretinal edema in both eyes and improvement after intravitreal ranibizumab.
A: Baseline superficial capillary plexus (internal limiting membrane to inner plexiform layer) (right eye); B: Baseline deep capillary plexus (inner plexiform layer to outer plexiform layer) (right eye); C: 1 mo after intravitreal ranibizumab (IVR) (superficial; right eye); D: 1 mo after IVR (deep; right eye); E: 6 mo after IVR (superficial; right eye); F: 6 mo after IVR (deep; right eye); G: Baseline (the whole sensory retina; left eye); H: 1 mo after IVR (the whole sensory retina; left eye).
Figure 5 Transverse structural optical coherence tomography angiography images.
A: Dilated choroidal large blood vessels on the right eye; B: Improvement 1 mo after intravitreal ranibizumab; C: Dilated choroidal large blood vessels on the left eye; D: Improvement 1 mo after intravitreal ranibizumab.
- Citation: Li J, Zhang R, Gu F, Liu ZL, Sun P. Optical coherence tomography angiography characteristics in Waldenström macroglobulinemia retinopathy: A case report. World J Clin Cases 2020; 8(23): 6071-6079
- URL: https://www.wjgnet.com/2307-8960/full/v8/i23/6071.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i23.6071